PAB - think those results are still in-vitro.
"The Patrys team is encouraged that multiple studies with cultured cancer cells and human cancer tissue explants confirm that PAT-DX1 is able to penetrate into cell nuclei and cause cancer cell death................................. the humanized version of 3E10, PAT-DX1, is an outstanding candidate to progress towards the clinic".
- Forums
- ASX - Day Trading
- morning traders 14 / 9
morning traders 14 / 9, page-75
-
- There are more pages in this discussion • 63 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)